AUDREY STROCK: Open Payments
NPI 1356561161 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177,686 in 342 payments from 15 companies in 2025. Trend: 2023 $124,561 · 2024 $133,717 · 2025 $177,686
Speaker / faculty: $129,255Travel & lodging: $30,880Honoraria: $13,001Food & beverage: $4,550
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 261 | $155,100 |
| Axsome Therapeutics, Inc. | 24 | $15,572 |
| Vanda Pharmaceuticals Inc. | 20 | $6,113 |
| Alkermes, Inc. | 9 | $312 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $111 |
| Collegium Pharmaceutical, Inc. | 4 | $70 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
Products named: VRAYLAR, Auvelity, FANAPT, CAPLYTA, ARISTADA, LYBALVI, TRINTELLIX, REXULTI.
Industry payments across CO — which companies pay providers there.
